Stenting improves long-term survival for patients with complete blockages undergoing percutaneous coronary intervention
New data demonstrates lower risk of cardiovascular death at six months and lower incidence of cardiac arrest at one year compared to non-stenting
2025-05-01
(Press-News.org) Washington, D.C. – MAY 1, 2025 – In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
Coronary artery disease (CAD) is the most common type of heart disease and a leading cause of death worldwide. CTO PCI is a minimally invasive procedure to treat CAD by reopening blocked arteries with a catheter and stent. CTO PCI is a challenging procedure and has been associated with lower success and higher in-hospital event rates compared to non-CTO PCI. The decision to place a stent may significantly impact clinical outcomes. While stenting improves blood vessel blockage or obstruction, the long-term benefits of stenting in CTO PCI remain debated.
The retrospective, single-center observational study evaluated the association between stented versus non-stented CTOs at a high-volume PCI center. Patients were stratified into stented and non-stented groups. Baseline characteristics were assessed using descriptive statistics.
A total of 677 patients underwent CTO PCI, with 81.2% receiving stents. Stenting was associated with improved long-term outcomes, including a lower risk of cardiovascular death at six months (adjusted odds ratio 0.20, 95% confidence interval 0.06–0.71) and a lower incidence of cardiac arrest at one year (adjusted odds ratio 0.21, 95% confidence interval 0.06–0.72). No significant differences were observed in 30-day all-cause mortality or in-hospital complications.
“While stenting is widely accepted as beneficial for patients with total blockages, the data presented at SCAI Scientific Sessions provides further evidence that it should be considered safe and effective in the long term,” said M Chadi Alraies, MD, MPH, FACC, FSCAI, Clinical Associate Professor of Medicine at Wayne State University School of Medicine, Medical Director Cardiac Catheterization Lab at Detroit Medical Center in Detroit, Mich. and lead author of the study. “Our study provides evidence that stenting can be an important treatment option for patients undergoing CTO PCI.”
The authors note that further studies are needed to refine treatment strategies and optimize CTO PCI outcomes.
Session Details:
“Clinical Outcomes of Stented vs. Non-Stented Chronic Total Occlusion Patients”
Thursday, May 1, 2025; 11:17-11:25 AM ET
Walter E. Washington Convention Center, Exhibit Hall D
###
About Society for Cardiovascular Angiography & Interventions (SCAI)
The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 5,000 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit https://scai.org/.
For more information about the SCAI 2025 Scientific Sessions, visit https://scai.org/scai-2025-scientific-sessions. Follow @SCAI on X for the latest heart health news and use #SCAI2025 to follow the latest discussions.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-05-01
Washington, D.C. – MAY 1, 2025 – The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse event rates at 30 days, compared to outpatient hospital departments, but were less likely to use certain technologies. The late-breaking data were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
Ambulatory surgery centers (ASCs) are non-hospital facilities that provide same-day surgical or procedural ...
2025-05-01
Background and Aims
Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide. This study aimed to explore the role of TM6SF2 in high-fat diet (HFD)-induced MASLD through the gut-liver axis.
Methods
The TM6SF2 gut-specific knockout (TM6SF2 GKO) mouse was constructed using CRISPR/Cas9 technology. TM6SF2 GKO and wild-type (CON) mice were fed either a HFD or a control diet for 16 weeks to induce MASLD. Blood, liver, and intestinal lipid content, as well as gut microbiota and serum metabolites, were then analyzed.
Results
TM6SF2 GKO ...
2025-05-01
Washington, D.C. – MAY 1, 2025 – In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including care escalation, CS deterioration, or in-hospital mortality. The data were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions.
CS is a life-threatening condition in which the heart cannot pump enough blood to meet the body’s needs. As a result, your blood pressure may suddenly drop to dangerous levels, and if CS isn’t diagnosed and treated ...
2025-05-01
FORT LAUDERDALE, Fla. — A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid, the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced today.
With funding from SILC, NSU researchers led by Dr. Nancy Klimas are enrolling 100 patients in the multi-year study with the goal of improving their Long Covid symptoms and restoring them to full health.
“Like ...
2025-05-01
COLUMBUS, Ohio – A new study shows how damaging it can be for college students in introductory STEM classes to compare how hard they work to the extent of effort put in by their peers.
Researchers studied students in an introductory chemistry class, one of the STEM (Science, Technology, Engineering and Mathematics) fields. They found that those who thought they had to work harder than others in class were less likely to believe they had the ability to succeed in science.
This focus on comparative effort was bad for both men and women in the class. But women showed positive effects of thinking they tried hard in the class ...
2025-05-01
For years, estrogens were known as the reproductive hormones produced by the ovaries, but recent discoveries reveal that these hormones are also synthesized in the brain through an enzyme called aromatase. This brain-specific version of estrogen is called neuroestrogen, and while its presence has been known, its precise function remained unclear—until now. Researchers from Fujita Health University reveal a groundbreaking discovery suggesting the direct role of neuroestrogen in appetite regulation.
“It is well known that MC4R (melanocortin-4 receptor) is an important receptor in the brain that regulates food intake,” explains lead author Takanori Hayashi, Associate Professor ...
2025-05-01
Could it be possible to diagnose Parkinson's disease with the help of a simple retinal exam? The idea should be seriously considered, according to a study published in the May issue of Neurobiology of Disease by researchers from Université Laval who discovered that the retina of people with Parkinson's disease responds differently to light stimuli than that of healthy people.
Parkinson's disease is usually diagnosed when a person consults a doctor because of motor problems such as tremors. “By then, the disease has been present for several ...
2025-05-01
Scientists have for the first time provided insight into how bomb residue transfers to the hands of suspects, which could lead to stronger evidence in court.
The study, which was led by a team from King’s College London and published today in the journal Science & Justice, investigated how explosive materials commonly found in pipe bombs and improvised explosive devices (IEDs) transferred to the palms and fingers of individuals who handled them. The researchers learned that the amount that was handled and the unique characteristics of the handler were important determining factors. Surprisingly, ...
2025-05-01
Parenting in the hospital is stressful. Moms and dads naturally focus on their ill child, sometimes to the neglect of their own mental health.
A Stanford Medicine team has found an effective way to help: Using a virtual reality headset, parents of inpatients at Lucile Packard Children’s Hospital Stanford can participate in a short, guided meditation that helps them relax and build healthy coping skills.
The VR-guided meditation reduced parental anxiety by about 30% in a study that was published recently in the Journal of Patient Experience. It was especially helpful for Spanish-speaking families, ...
2025-05-01
Whether they’re counting on Medicare to pay for something it doesn’t currently pay for, thinking they can deal with the issue later, or thinking they won’t need it at all, a new poll reveals major gaps in knowledge and preparation regarding long-term care among Americans aged 50 and over.
Nearly two-thirds (62%) believe Medicare would pay for their care if they needed to permanently move into a nursing home. But Medicare generally doesn’t cover this kind of care. It also doesn’t pay family caregivers to take care of someone at home.
The poll also asked about Medicaid, which ...
LAST 30 PRESS RELEASES:
[Press-News.org] Stenting improves long-term survival for patients with complete blockages undergoing percutaneous coronary intervention
New data demonstrates lower risk of cardiovascular death at six months and lower incidence of cardiac arrest at one year compared to non-stenting
